KLRS (Kalaris Therapeutics, Inc.) Stock Market Reviews

crown

search

Read and share opinions on KLRS (Kalaris Therapeutics, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock mark

KLRS

Kalaris Therapeutics, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Kalaris to Present at Stifel 2025 Annual Healthcare Conference
Oct 30, 2025
UPDATE – Kalaris Therapeutics Now Enrolling Phase 1b/2 Multiple Ascending Dose Study of TH103 in Neovascular Age-Related Macular Degeneration
Sep 15, 2025
Kalaris Therapeutics Inc. (KLRS) Upgraded to Buy: Here's What You Should Know
Sep 1, 2025
Kalaris Reports Second Quarter 2025 Financial Results and Provides Business Updates
Aug 13, 2025
Kalaris to Present at Noble Capital Markets 2025 Emerging Growth Equity Conference
Jun 2, 2025
Kalaris to Participate at Stifel Ophthalmology Forum
May 23, 2025
Kalaris Reports First Quarter 2025 Financial Results and Provides Business Highlights
May 14, 2025
Kalaris Expands Board of Directors Appointing Leone Patterson as Chair of Audit Committee
Apr 4, 2025

Reviews